---
title: "If You Invested $1000 In Regeneron Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295958013.md"
description: "Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years with an annualized return of 22.03%. An initial $1,000 investment would be worth $53,623.41 today. The company currently holds a market capitalization of $82.54 billion, highlighting the power of compounded returns."
datetime: "2026-08-14T16:15:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295958013.md)
  - [en](https://longbridge.com/en/news/295958013.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295958013.md)
---

# If You Invested $1000 In Regeneron Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 12.69% on an annualized basis producing an average annual return of 22.03%. Currently, Regeneron Pharmaceuticals has a market capitalization of $82.54 billion.

**Buying $1000 In REGN:** If an investor had bought $1000 of REGN stock 20 years ago, it would be worth **$53,623.41** today based on a price of $801.67 for REGN at the time of writing.

### Regeneron Pharmaceuticals’s Performance Over Last 20 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/08/14/3baa23fafe6c297ea27508e1096e2704.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

_This article was generated by Benzinga's automated content engine and reviewed by an editor._

### Related Stocks

- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)

## Related News & Research

- [12:50 ETREGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt](https://longbridge.com/en/news/295826897.md)
- [USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/296020218.md)
- [15:34 ETRegeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman](https://longbridge.com/en/news/295967459.md)
- [NewEdge Advisors LLC Has $5.88 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/295508474.md)
- [Beacon Investment Advisory Services Inc. Sells 9,055 Shares of Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/295318452.md)